TIAA CREF INVESTMENT MANAGEMENT LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 199 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2019$1,129,000
+28.3%
303,3910.0%0.00%0.0%
Q4 2018$880,000
-49.6%
303,391
-54.3%
0.00%0.0%
Q3 2018$1,746,000
+111.6%
664,220
+88.4%
0.00%0.0%
Q2 2018$825,000
-25.9%
352,619
-7.0%
0.00%0.0%
Q1 2018$1,114,000
-12.8%
378,995
-18.7%
0.00%0.0%
Q4 2017$1,277,000
-45.5%
466,195
-32.5%
0.00%
-50.0%
Q3 2017$2,342,000
+114.1%
690,721
+55.9%
0.00%
+100.0%
Q2 2017$1,094,000
+7.5%
443,001
-1.2%
0.00%0.0%
Q1 2017$1,018,000
-0.7%
448,514
-7.2%
0.00%0.0%
Q4 2016$1,025,000
-45.7%
483,359
-14.3%
0.00%0.0%
Q3 2016$1,889,000
-10.1%
563,870
-15.7%
0.00%
-50.0%
Q2 2016$2,101,000
+18.0%
668,990
+25.1%
0.00%
+100.0%
Q1 2016$1,781,000
-4.6%
534,775
+1.4%
0.00%0.0%
Q4 2015$1,866,000
-30.5%
527,216
-1.2%
0.00%
-50.0%
Q3 2015$2,684,000
-24.2%
533,694
-3.1%
0.00%
-33.3%
Q2 2015$3,542,000
-7.2%
550,904
+1.5%
0.00%0.0%
Q1 2015$3,818,000
-11.3%
542,748
-2.8%
0.00%0.0%
Q4 2014$4,306,000
-2.3%
558,475
-5.3%
0.00%0.0%
Q3 2014$4,407,000
-24.0%
589,910
-1.6%
0.00%
-25.0%
Q2 2014$5,800,000
-14.8%
599,215
-26.9%
0.00%
-20.0%
Q1 2014$6,808,000
-12.1%
819,266
-10.7%
0.01%
-16.7%
Q4 2013$7,745,000
+10.9%
917,702
+4.7%
0.01%
+20.0%
Q3 2013$6,983,000
+1.9%
876,122
-1.3%
0.01%
-16.7%
Q2 2013$6,853,000887,7530.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,465,000$3,853,0001.56%
SMH CAPITAL ADVISORS INC 93,708$246,0000.42%
West Family Investments, Inc. 627,800$1,651,0000.39%
KENNEDY CAPITAL MANAGEMENT LLC 7,082,858$18,628,0000.35%
ARMISTICE CAPITAL, LLC 1,800,000$4,734,0000.28%
BRANDES INVESTMENT PARTNERS, LP 3,936,719$10,354,0000.23%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$38,0000.13%
Zebra Capital Management LLC 74,695$196,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 5,968,105$15,696,0000.09%
CREDIT AGRICOLE S A 471,644$1,240,0000.06%
View complete list of PDL BIOPHARMA INC shareholders